我們已在上線! 進一步了解
IOSP圖示

Innospec

96.81 USD
+0.21
0.22%
收盤時 已更新 10月16日 下午4:00 EDT
盤前交易
盤後交易
96.81
0.00
0%
1天
0.22%
5天
1.16%
1個月
4.18%
3個月
13.28%
6個月
28.93%
今年迄今
26.91%
1年
30.49%
5年
11.38%
10年
57.85%
 

關於: Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

員工: 2,450

新聞

正面
中性
負面
市場情緒 3個月
正面 53.8%
中性 38.5%
負面 7.7%
中性
GlobeNewsWire
11 天前
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
正面
Zacks Investment Research
上個月
Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?
Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?
Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?
正面
Zacks Investment Research
上個月
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
中性
Seeking Alpha
2 個月前
Innospec: Topline Is Growing As Expected
With the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.
Innospec: Topline Is Growing As Expected
正面
Zacks Investment Research
2 個月前
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
正面
Zacks Investment Research
2 個月前
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
中性
Seeking Alpha
2 個月前
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
正面
MarketBeat
2 個月前
Innospec Q2 Earnings Call Highlights
Innospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.
Innospec Q2 Earnings Call Highlights
正面
Zacks Investment Research
2 個月前
Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates
Innospec (IOSP) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.26 per share a year ago.
Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates
中性
GlobeNewsWire
2 個月前
Innospec Reports Second Quarter 2026 Financial Results
Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent
Innospec Reports Second Quarter 2026 Financial Results
價格圖表採用Lightweight Charts™實作